Researchers at Karolinska Institutet have
identified cell surface markers specific for the very earliest stem cells in the human embryo.
Not exact matches
Weeks later, Yee realized that he didn't have the equipment he needed to pluck out of Ziskin's blood the rare (perhaps one in 100,000) T
cells that could
identify the subtle peptide
markers on the
surface of her cancer
cells and attack the disease.
Several studies have used
cell -
surface markers — proteins found on the outer membranes of tumor
cells — to
identify glioblastoma stem
cells; but the specific
markers used have been controversial and can not reflect molecular processes going on within tumor
cells.
The cancer
cell marker that Johnson and her team
identified was a specific change in protein glycosylation, that is, a unique pattern of sugars decorating a protein found on the
cell surface.
Once they were able to isolate skeletal muscle
cells using the newly
identified surface markers, the research team matured those
cells in the lab to create dystrophin - producing muscle fibers.
In breast cancer, CSCs or tumor - initiating
cells were first
identified by using a combination of
cell surface markers, CD24 − / CD44 + / ESA (EpCAM) + (2).
HLA (human leukocyte antigen)-
markers on the
surface of a body's
cell that
identify the
cell as one's own (as opposed to a foreign
cell) and prevent the immune system from attacking itself.
There are no specific
markers to
identify them; however, they are negative for hematopoietic
cell markers like CD34 / 45 / HLA - DR and express CD90 / 73/105 on their
surface 2, 3, 4.
Macrophages were
identified by their typical morphology, as well as by their reactivity to the
cell surface marker F4 / 80 (Fig. 2A) ⇓.
Since very few studies have demonstrated the formation of macro-metastasis from low numbers of sorted CSCs and currently proposed CSC
markers might not be sufficient to
identify all stem
cell populations [13], we believe that our study presents a promising approach to isolate stem - like and metastatic breast CSCs as opposed to the
cell - sorting strategy based on putative stem
cell surface markers.
Luckily, different
cell types tend to have different things on their
surfaces, which play particular parts in their specialized roles in the tissue, so it is a matter of
identifying and targeting
cell -
surface markers that are specific to these abnormal
cell types.
Most of these CSCs have been
identified using
surface markers that
identify their corresponding normal tissue stem and progenitor
cells, thus reinforcing the resemblance of tumor development to normal organogenesis.
Haihui Lu, Ph.D., a CRI fellow at the Whitehead Institute for Biomedical Research, has
identified a
surface marker that distinguishes a population of breast cancer
cells that are more prone to metastasis and demonstrate higher levels of «stemness,» the ability to seed other tumors.